MFDS — authorised 25 May 2023
- Marketing authorisation holder: BLUE EARTH
- Status: likely_approved
🇰🇷 Posluma in South Korea
MFDS authorised Posluma on 25 May 2023
Marketing authorisation
Posluma in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Oncology approved in South Korea
Frequently asked questions
Is Posluma approved in South Korea?
Yes. MFDS authorised it on 25 May 2023.
Who is the marketing authorisation holder for Posluma in South Korea?
BLUE EARTH holds the South Korean marketing authorisation.